speb/financial-data huggingface dataset:
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1834310000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 150073000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 5931039000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1356475000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 2580319000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 30720000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.23
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1229402000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 7167000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 7167000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 30720000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.23
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 6912000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — EBIT: 20655000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — EBITDA: 27822000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1350917000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 4630000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 4630000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Net Income: 6912000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 6912000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 6778000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 134000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 6912000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 6778000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 6912000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -4630000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -4630000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 45785000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 19352100.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Operating Income: -5558000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 2580319000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 44178000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1349308000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 16025000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1229402000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 7167000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -17963000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -5388900.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 9246000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 2585877000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -17963000.00
TRIGYN.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -17963000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — +Operating Expense: 4859426000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1263034000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — +Total Revenue: 9764294000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 2519463000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 905461000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 905461000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 2499785000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2499785000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 884000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 884000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 704084000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 704084000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 30563077.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 30100000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Basic EPS: 0.65
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.21
TRIGYN.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 4130622000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -17041000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 37862000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 37862000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 307857000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 307857000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 4740096000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 4740096000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4936831000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4936831000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 284000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 7145000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Change In Payable: 205718000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -415496000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -202349000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 80693000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Common Stock: 307857000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 307857000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 7967192000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 7967192000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 4899461000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1227831000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Current Assets: 7898898000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 7898898000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 7687000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 7687000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Current Debt: 64729000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 64729000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 72416000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 72416000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 1696337000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1696337000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 125194000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 125194000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Depreciation: 30867000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 30867000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 30867000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 7324000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 30867000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 7324000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 30563077.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 30100000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Diluted EPS: 0.65
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.21
TRIGYN.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 19866000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 6321000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 111056000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — EBIT: 159702000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — EBIT: 71518000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — EBITDA: 190569000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — EBITDA: 78842000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 528780000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — End Cash Position: 4740096000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -25455000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -108573000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -109528000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Goodwill: 867433000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 867433000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 904818000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 904818000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 50483000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 50483000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Gross Profit: 4864833000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1291632000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Interest Expense: 25223000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 8941000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 25223000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 8941000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -25242000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 62623000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Inventory: 88097000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 88097000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 8031921000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8031921000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 197680000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 704084000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 704084000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 30175000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 30175000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 30175000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 30175000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 127760000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 127760000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 39607000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Net Income: 19866000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Net Income: 6321000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 19866000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 6321000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 23418000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 7181000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Net Income Discontinuous Operations: -3552000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: -860000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 19866000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 6321000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 23418000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 7181000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 130927000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 19866000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 6321000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Net Interest Income: -25223000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -8941000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 40935000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -213000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -213000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -25223000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -8941000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 107000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Net PPE: 50483000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 50483000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -17041000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 7062374000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 7062374000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 95615000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 95615000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 210061000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 80370000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Normalized Income: 35113200.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 8097800.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -91532000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Operating Income: 5407000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Operating Income: 28598000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Operating Revenue: 9764294000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 2519463000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 30785736.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 30785736.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 313970000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 313970000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 58936000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 58936000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 7659335000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 7659335000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 37385000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 37385000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -19526000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 84526000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 84526000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 1000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 173787000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 44447000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 4828559000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1255710000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Other Properties: 50483000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 50483000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 196735000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 196735000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Payables: 905461000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Payables: 905461000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 654000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Pretax Income: 134479000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 62577000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 4899461000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1227831000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 30867000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 7324000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Share Issued: 30785736.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 30785736.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Special Income Charges: -19492000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: -1528000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 7967192000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 7967192000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 7062374000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 7062374000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -7796800.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -611200.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Tax Provision: 111060000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 55395000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 59331000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 59331000.00
TRIGYN.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -82034000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Total Assets: 9821465000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 9821465000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 7967192000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 7967192000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Total Debt: 102591000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 102591000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 7967192000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 7967192000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Total Expenses: 9758887000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 2490865000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 1854273000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1854273000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 1922567000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1922567000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 157936000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 157936000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -19492000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -1528000.00
TRIGYN.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -19492000.00
TRIGYN.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -1528000.00
TRIGYN.NS balance_sheet (annual, 2026-03-31) — Working Capital: 6202561000.00
TRIGYN.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 6202561000.00
TRIN cash_flow (annual, 2021-12-31) — Change In Prepaid Assets: 51000.00
TRIN cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
TRIN balance_sheet (annual, 2021-12-31) — Prepaid Assets: 693000.00
TRIN cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
TRIN cash_flow (annual, 2021-12-31) — Purchase Of PPE: -1204000.00
TRIN income_statement (annual, 2022-12-31) — +Operating Expense: 37377000.00
TRIN income_statement (annual, 2022-12-31) — +Total Revenue: 9391000.00
TRIN balance_sheet (annual, 2022-12-31) — Accounts Payable: 21326000.00
TRIN balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 480532000.00
TRIN income_statement (annual, 2022-12-31) — Average Dilution Earnings: 0.00
TRIN income_statement (annual, 2022-12-31) — Basic Average Shares: 31672089.00
TRIN income_statement (annual, 2022-12-31) — Basic EPS: -0.96
TRIN cash_flow (annual, 2022-12-31) — Beginning Cash Position: 46742000.00
TRIN cash_flow (annual, 2022-12-31) — Capital Expenditure: -194000.00
TRIN balance_sheet (annual, 2022-12-31) — Capital Stock: 35000.00
TRIN balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 10612000.00
TRIN balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 13053000.00
TRIN cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -61155000.00
TRIN balance_sheet (annual, 2022-12-31) — Cash Equivalents: 5643000.00
TRIN balance_sheet (annual, 2022-12-31) — Cash Financial: 4969000.00
TRIN cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 674000.00
TRIN cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 4260000.00
TRIN cash_flow (annual, 2022-12-31) — Change In Payable: 5177000.00
TRIN cash_flow (annual, 2022-12-31) — Change In Receivables: -4420000.00
TRIN cash_flow (annual, 2022-12-31) — Change In Working Capital: 5691000.00
TRIN cash_flow (annual, 2022-12-31) — Changes In Cash: -36130000.00
TRIN balance_sheet (annual, 2022-12-31) — Common Stock: 35000.00
TRIN cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -61155000.00
TRIN balance_sheet (annual, 2022-12-31) — Common Stock Equity: 459649000.00
TRIN cash_flow (annual, 2022-12-31) — Common Stock Issuance: 113141000.00
TRIN cash_flow (annual, 2022-12-31) — Common Stock Payments: -3034000.00
TRIN income_statement (annual, 2022-12-31) — Diluted Average Shares: 35189709.00
TRIN income_statement (annual, 2022-12-31) — Diluted EPS: -0.96
TRIN income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -30375000.00
TRIN cash_flow (annual, 2022-12-31) — End Cash Position: 10612000.00
TRIN balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1094386000.00
TRIN cash_flow (annual, 2022-12-31) — Financing Cash Flow: 199806000.00
TRIN cash_flow (annual, 2022-12-31) — Free Cash Flow: -235936000.00
TRIN cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -188696000.00
TRIN income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 32853000.00
TRIN income_statement (annual, 2022-12-31) — General And Administrative Expense: 10188000.00
TRIN income_statement (annual, 2022-12-31) — Interest Expense: 34148000.00
TRIN income_statement (annual, 2022-12-31) — Interest Income: 138836000.00
TRIN balance_sheet (annual, 2022-12-31) — Invested Capital: 1070242000.00
TRIN cash_flow (annual, 2022-12-31) — Investing Cash Flow: -194000.00
TRIN balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 1094386000.00
TRIN balance_sheet (annual, 2022-12-31) — Investments And Advances: 1094386000.00
TRIN cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 113141000.00
TRIN cash_flow (annual, 2022-12-31) — Issuance Of Debt: 380354000.00
TRIN balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 610593000.00
TRIN cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 380354000.00
TRIN cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -229500000.00
TRIN cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
TRIN cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 110107000.00
TRIN balance_sheet (annual, 2022-12-31) — Net Debt: 599981000.00
TRIN income_statement (annual, 2022-12-31) — Net Income: -30375000.00
TRIN income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -30375000.00
TRIN income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -30375000.00
TRIN income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -30375000.00
TRIN income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -30375000.00
TRIN cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -30375000.00
TRIN income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -30375000.00
TRIN income_statement (annual, 2022-12-31) — Net Interest Income: 104688000.00
TRIN cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 150854000.00
TRIN cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 150854000.00
TRIN cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 0.00
TRIN cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -194000.00
TRIN balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 459649000.00
TRIN income_statement (annual, 2022-12-31) — Normalized Income: -30375000.00
TRIN cash_flow (annual, 2022-12-31) — Operating Cash Flow: -235742000.00
TRIN income_statement (annual, 2022-12-31) — Operating Revenue: 9391000.00
TRIN balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 34960672.00
TRIN cash_flow (annual, 2022-12-31) — Other Non Cash Items: -22362000.00
TRIN balance_sheet (annual, 2022-12-31) — Payables: 21326000.00
TRIN income_statement (annual, 2022-12-31) — Pretax Income: -27986000.00
TRIN cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
TRIN cash_flow (annual, 2022-12-31) — Purchase Of PPE: -194000.00
TRIN balance_sheet (annual, 2022-12-31) — Receivables: 9971000.00
TRIN cash_flow (annual, 2022-12-31) — Repayment Of Debt: -229500000.00
TRIN cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -3034000.00
TRIN balance_sheet (annual, 2022-12-31) — Retained Earnings: -20918000.00
TRIN income_statement (annual, 2022-12-31) — Selling General And Administration: 10188000.00
TRIN balance_sheet (annual, 2022-12-31) — Share Issued: 34960672.00
TRIN balance_sheet (annual, 2022-12-31) — Stockholders Equity: 459649000.00
TRIN balance_sheet (annual, 2022-12-31) — Tangible Book Value: 459649000.00
TRIN income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
TRIN income_statement (annual, 2022-12-31) — Tax Provision: 2389000.00
TRIN income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
TRIN balance_sheet (annual, 2022-12-31) — Total Assets: 1126439000.00
TRIN balance_sheet (annual, 2022-12-31) — Total Capitalization: 1070242000.00
TRIN balance_sheet (annual, 2022-12-31) — Total Debt: 610593000.00
TRIN balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 459649000.00
TRIN balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 666790000.00
TRIN income_statement (annual, 2023-12-31) — +Operating Expense: 45098000.00
TRIN income_statement (annual, 2023-12-31) — +Total Revenue: 124551000.00
TRIN balance_sheet (annual, 2023-12-31) — Accounts Payable: 23162000.00
TRIN balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 633740000.00
TRIN income_statement (annual, 2023-12-31) — Average Dilution Earnings: 3639000.00
TRIN income_statement (annual, 2023-12-31) — Basic Average Shares: 38910150.00
TRIN income_statement (annual, 2023-12-31) — Basic EPS: 1.98
TRIN cash_flow (annual, 2023-12-31) — Beginning Cash Position: 10612000.00
TRIN cash_flow (annual, 2023-12-31) — Capital Expenditure: -2744000.00
TRIN balance_sheet (annual, 2023-12-31) — Capital Stock: 46000.00
TRIN balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 4761000.00
TRIN balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 7202000.00
TRIN cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -78802000.00
TRIN balance_sheet (annual, 2023-12-31) — Cash Equivalents: 3088000.00
TRIN balance_sheet (annual, 2023-12-31) — Cash Financial: 1673000.00
TRIN cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -6380000.00
TRIN cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -2813000.00
TRIN cash_flow (annual, 2023-12-31) — Change In Payable: 4989000.00
TRIN cash_flow (annual, 2023-12-31) — Change In Receivables: -1256000.00
TRIN cash_flow (annual, 2023-12-31) — Change In Working Capital: -5460000.00
TRIN cash_flow (annual, 2023-12-31) — Changes In Cash: -5851000.00
TRIN balance_sheet (annual, 2023-12-31) — Common Stock: 46000.00
TRIN cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -78802000.00
TRIN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 611159000.00
TRIN cash_flow (annual, 2023-12-31) — Common Stock Issuance: 150279000.00
TRIN cash_flow (annual, 2023-12-31) — Common Stock Payments: -3824000.00
TRIN income_statement (annual, 2023-12-31) — Diluted Average Shares: 42705875.00
TRIN income_statement (annual, 2023-12-31) — Diluted EPS: 1.89
TRIN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 80532000.00
TRIN cash_flow (annual, 2023-12-31) — End Cash Position: 4761000.00
TRIN balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1275180000.00
TRIN cash_flow (annual, 2023-12-31) — Financing Cash Flow: 93153000.00
TRIN cash_flow (annual, 2023-12-31) — Free Cash Flow: -99004000.00
TRIN cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -147820000.00
TRIN income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -28071000.00
TRIN income_statement (annual, 2023-12-31) — General And Administrative Expense: 12005000.00
TRIN income_statement (annual, 2023-12-31) — Interest Expense: 44296000.00
TRIN income_statement (annual, 2023-12-31) — Interest Income: 174840000.00
TRIN balance_sheet (annual, 2023-12-31) — Invested Capital: 1250773000.00
TRIN cash_flow (annual, 2023-12-31) — Investing Cash Flow: -2744000.00
TRIN balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 1275180000.00
TRIN balance_sheet (annual, 2023-12-31) — Investments And Advances: 1275180000.00
TRIN cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 150279000.00
TRIN cash_flow (annual, 2023-12-31) — Issuance Of Debt: 420000000.00
TRIN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 639614000.00
TRIN cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 420000000.00
TRIN cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -394500000.00
TRIN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 146455000.00
TRIN balance_sheet (annual, 2023-12-31) — Net Debt: 634853000.00
TRIN income_statement (annual, 2023-12-31) — Net Income: 76893000.00
TRIN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 76893000.00
TRIN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 76893000.00
TRIN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 76893000.00
TRIN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 76893000.00
TRIN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 76893000.00
TRIN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 76893000.00
TRIN income_statement (annual, 2023-12-31) — Net Interest Income: 130544000.00
TRIN cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 25500000.00
TRIN cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 25500000.00
TRIN cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 0.00
TRIN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -2744000.00
TRIN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 611159000.00
TRIN income_statement (annual, 2023-12-31) — Normalized Income: 76893000.00
TRIN cash_flow (annual, 2023-12-31) — Operating Cash Flow: -96260000.00
TRIN income_statement (annual, 2023-12-31) — Operating Revenue: 124551000.00
TRIN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 46323712.00
TRIN cash_flow (annual, 2023-12-31) — Other Non Cash Items: -19873000.00
TRIN balance_sheet (annual, 2023-12-31) — Payables: 23162000.00
TRIN income_statement (annual, 2023-12-31) — Pretax Income: 79453000.00
TRIN balance_sheet (annual, 2023-12-31) — Receivables: 11206000.00
TRIN cash_flow (annual, 2023-12-31) — Repayment Of Debt: -394500000.00
TRIN cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -3824000.00
TRIN balance_sheet (annual, 2023-12-31) — Retained Earnings: -22627000.00
TRIN income_statement (annual, 2023-12-31) — Selling General And Administration: 12005000.00
TRIN balance_sheet (annual, 2023-12-31) — Share Issued: 46323712.00
TRIN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 611159000.00
TRIN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 611159000.00
TRIN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
TRIN income_statement (annual, 2023-12-31) — Tax Provision: 2560000.00
TRIN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.03
TRIN balance_sheet (annual, 2023-12-31) — Total Assets: 1310982000.00
TRIN balance_sheet (annual, 2023-12-31) — Total Capitalization: 1250773000.00
TRIN balance_sheet (annual, 2023-12-31) — Total Debt: 639614000.00
TRIN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 611159000.00
TRIN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 699823000.00
TRIN balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
TRIN income_statement (annual, 2024-12-31) — +Operating Expense: 57220000.00
TRIN income_statement (annual, 2024-12-31) — +Total Revenue: 175494000.00
TRIN balance_sheet (annual, 2024-12-31) — Accounts Payable: 31451000.00
TRIN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 829626000.00
TRIN income_statement (annual, 2024-12-31) — Average Dilution Earnings: 3645000.00
TRIN income_statement (annual, 2024-12-31) — Basic Average Shares: 52705732.00
TRIN income_statement (annual, 2024-12-31) — Basic EPS: 2.19
TRIN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 4761000.00
TRIN cash_flow (annual, 2024-12-31) — Capital Expenditure: -420000.00
TRIN balance_sheet (annual, 2024-12-31) — Capital Stock: 62000.00
TRIN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 9627000.00
TRIN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 9627000.00
TRIN cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -102532000.00
TRIN balance_sheet (annual, 2024-12-31) — Cash Equivalents: 3750000.00
TRIN balance_sheet (annual, 2024-12-31) — Cash Financial: 5877000.00
TRIN cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 2195000.00
TRIN cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -3815000.00
TRIN cash_flow (annual, 2024-12-31) — Change In Payable: 8903000.00
TRIN cash_flow (annual, 2024-12-31) — Change In Receivables: -5336000.00
TRIN cash_flow (annual, 2024-12-31) — Change In Working Capital: 1947000.00
TRIN cash_flow (annual, 2024-12-31) — Changes In Cash: 4866000.00
TRIN balance_sheet (annual, 2024-12-31) — Common Stock: 62000.00
TRIN cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -102532000.00
TRIN balance_sheet (annual, 2024-12-31) — Common Stock Equity: 822982000.00
TRIN cash_flow (annual, 2024-12-31) — Common Stock Issuance: 200231000.00
TRIN cash_flow (annual, 2024-12-31) — Common Stock Payments: -3726000.00
TRIN income_statement (annual, 2024-12-31) — Diluted Average Shares: 56728848.00
TRIN income_statement (annual, 2024-12-31) — Diluted EPS: 2.10
TRIN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 119241000.00
TRIN cash_flow (annual, 2024-12-31) — End Cash Position: 9627000.00
TRIN balance_sheet (annual, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1725570000.00
TRIN cash_flow (annual, 2024-12-31) — Financing Cash Flow: 322195000.00
TRIN cash_flow (annual, 2024-12-31) — Free Cash Flow: -317329000.00
TRIN cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -410816000.00
TRIN income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -9730000.00
TRIN income_statement (annual, 2024-12-31) — General And Administrative Expense: 14176000.00
TRIN income_statement (annual, 2024-12-31) — Interest Expense: 61948000.00
TRIN income_statement (annual, 2024-12-31) — Interest Income: 226729000.00
TRIN balance_sheet (annual, 2024-12-31) — Invested Capital: 1700655000.00
TRIN cash_flow (annual, 2024-12-31) — Investing Cash Flow: -420000.00
TRIN balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 1725570000.00
TRIN balance_sheet (annual, 2024-12-31) — Investments And Advances: 1725570000.00
TRIN cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 200231000.00
TRIN cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1187622000.00
TRIN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 877673000.00
TRIN cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1187622000.00
TRIN cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -959400000.00
TRIN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 196505000.00
TRIN balance_sheet (annual, 2024-12-31) — Net Debt: 868046000.00
TRIN income_statement (annual, 2024-12-31) — Net Income: 115596000.00
TRIN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 115596000.00
TRIN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 115596000.00
TRIN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 115596000.00
TRIN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 115596000.00
TRIN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 115596000.00
TRIN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 115596000.00
TRIN income_statement (annual, 2024-12-31) — Net Interest Income: 164781000.00
TRIN cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 228222000.00
TRIN cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 228222000.00
TRIN cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 0.00
TRIN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -420000.00
TRIN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 822982000.00
TRIN income_statement (annual, 2024-12-31) — Normalized Income: 115596000.00
TRIN cash_flow (annual, 2024-12-31) — Operating Cash Flow: -316909000.00
TRIN income_statement (annual, 2024-12-31) — Operating Revenue: 175494000.00
TRIN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 61669059.00
TRIN cash_flow (annual, 2024-12-31) — Other Non Cash Items: -23636000.00
TRIN income_statement (annual, 2024-12-31) — Other Operating Expenses: -473000.00
TRIN balance_sheet (annual, 2024-12-31) — Payables: 31451000.00
TRIN balance_sheet (quarterly, 2024-12-31) — Payables: 31451000.00
TRIN income_statement (annual, 2024-12-31) — Pretax Income: 118274000.00
TRIN balance_sheet (annual, 2024-12-31) — Receivables: 16542000.00
TRIN cash_flow (annual, 2024-12-31) — Repayment Of Debt: -959400000.00
TRIN cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -3726000.00
TRIN balance_sheet (annual, 2024-12-31) — Retained Earnings: -6706000.00
TRIN income_statement (annual, 2024-12-31) — Selling General And Administration: 14176000.00
TRIN balance_sheet (annual, 2024-12-31) — Share Issued: 61669059.00
TRIN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 822982000.00
TRIN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 822982000.00
TRIN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
TRIN income_statement (annual, 2024-12-31) — Tax Provision: 2678000.00
TRIN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.02
TRIN balance_sheet (annual, 2024-12-31) — Total Assets: 1774241000.00
TRIN balance_sheet (annual, 2024-12-31) — Total Capitalization: 1700655000.00
TRIN balance_sheet (annual, 2024-12-31) — Total Debt: 877673000.00
TRIN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 822982000.00
TRIN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 951259000.00
TRIN income_statement (quarterly, 2025-03-31) — +Operating Expense: 14730000.00
TRIN income_statement (quarterly, 2025-03-31) — +Total Revenue: 42433000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 32579000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 845531000.00
TRIN income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 0.00
TRIN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 62555531.00
TRIN income_statement (quarterly, 2025-03-31) — Basic EPS: 0.43
TRIN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 9627000.00
TRIN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -106000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 64000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 8386000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 8386000.00
TRIN cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -31154000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 3262000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Cash Financial: 5124000.00
TRIN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -17323000.00
TRIN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -1457000.00
TRIN cash_flow (quarterly, 2025-03-31) — Change In Payable: -8330000.00
TRIN cash_flow (quarterly, 2025-03-31) — Change In Receivables: -84000.00
TRIN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -27194000.00
TRIN cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1241000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Common Stock: 64000.00
TRIN cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -31154000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 833395000.00
TRIN cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 30468000.00
TRIN cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -1695000.00
TRIN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 62555531.00
TRIN income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.43
TRIN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 27087000.00
TRIN cash_flow (quarterly, 2025-03-31) — End Cash Position: 8386000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1792689000.00
TRIN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 62206000.00
TRIN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -63447000.00
TRIN cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -56075000.00
TRIN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -2154000.00
TRIN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 4493000.00
TRIN income_statement (quarterly, 2025-03-31) — Interest Expense: 17656000.00
TRIN income_statement (quarterly, 2025-03-31) — Interest Income: 62673000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1792349000.00
TRIN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -106000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 1792689000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 1792689000.00
TRIN cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 30468000.00
TRIN cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 401343000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 958954000.00
TRIN cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 401343000.00
TRIN cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -336756000.00
TRIN cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 28773000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Net Debt: 950568000.00
TRIN income_statement (quarterly, 2025-03-31) — Net Income: 27087000.00
TRIN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 27087000.00
TRIN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 27087000.00
TRIN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 27087000.00
TRIN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 27087000.00
TRIN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 27087000.00
TRIN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 27087000.00
TRIN income_statement (quarterly, 2025-03-31) — Net Interest Income: 45017000.00
TRIN cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 64587000.00
TRIN cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 64587000.00
TRIN cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 0.00
TRIN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -106000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 833395000.00
TRIN income_statement (quarterly, 2025-03-31) — Normalized Income: 27087000.00
TRIN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -63341000.00
TRIN income_statement (quarterly, 2025-03-31) — Operating Revenue: 42433000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 63880330.00
TRIN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -7159000.00
TRIN income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -408000.00
TRIN balance_sheet (quarterly, 2025-03-31) — Payables: 32579000.00